Personalized Nutrition, Blood Tests & Dementia Risk: A Harvard Scientist Explains the Science

Gene Bowman, ND, MPH, explains why nutrition, blood-based biomarkers, and personalized testing could change how we think about protecting brain health, and that people with suboptimal levels of just three blood markers may have a four-to-five-fold higher risk of dementia. Brain health is often treated as something to worry about only after memory, focus, or processing speed begins to decline. But Gene Bowman explains that the biological changes associated with cognitive decline begin decades earlier, and that emerging blood-based biomarkers and personalized nutrition could help identify risk and guide intervention much sooner.Gene Bowman, ND, MPH, is Clinical Trials Director at the McCance Center for Brain Health at Massachusetts General Hospital and a faculty member at Harvard Medical School, where his research focuses on nutritional neuroscience, cognitive aging, metabolic health, and blood-based biomarkers of brain health. On The LIVING Room Podcast, he joins Chris Wharton to explain why brain health is influenced by nutrient patterns rather than one "miracle" supplement, how APOE4 risk may interact with omega-3 status and lifestyle, and why ultra-processed foods, trans fats, refined sugars, and poor metabolic health may contribute to long-term brain agingWhat we cover in this conversation:• Why cognitive decline may begin decades before symptoms appear• How blood tests could reveal nutritional and metabolic risks to brain health• The combination of three nutritional markers linked to a four-to-five-fold higher risk of dementia• How personalized nutrition could support the future of Alzheimer's and dementia prevention• What APOE4 means for omega-3s, genetics, and long-term brain health• Why one supplement is rarely enough to protect cognitive function• How trans fats, refined sugars, and ultra-processed foods may affect the brain• What to eat for sharper focus today and greater cognitive resilience over time• Why "normal" nutrient levels may not be optimal for brain performance• How future brain-health testing could make prevention far more personalized and preciseFor anyone concerned about brain fog, family history, cognitive decline, or protecting their brain as they age, this episode offers a more proactive way to think about brain health: test earlier, understand your individual biology, and build the nutritional foundation that may help preserve cognitive function over time.Want more? Each month, we send a newsletter curated by our scientific council on what's actually advancing the science of human longevity — and what isn't. Subscribe at https://www.thewndrlab.com/mailing-list. The WNDR Lab: https://www.thewndrlab.com/  Connect with our host Chris Wharton on Instagram: https://www.instagram.com/chriswharton1Gene L. Bowman, ND, MPHLinkedIn: https://www.linkedin.com/in/gene-bowman-64b10b8/Harvard Profile: https://researchers.mgh.harvard.edu/profile/31831698/Gene-Bowmanhttps://connects.catalyst.harvard.edu/Profiles/display/Person/215473Episode ReferencesIndividuals:Rudy Tanzi — Harvard neurogeneticist who co-discovered the Huntington's and Alzheimer's genes and helped build the amyloid hypothesis.Martha Clare Morris — Developed the MIND diet and co-founded the AA-ISTAART Nutrition, --Metabolism, and Dementia group with Gene.Frank Sacks — Harvard researcher who developed the DASH diet.Diets / Frameworks:MIND diet — Dietary pattern (berries, leafy greens, seafood, nuts/seeds) linked to lower dementia risk observationally, but underperformed in its clinical trial.DASH diet — Diet designed for cardiovascular disease reduction; blended into the MIND diet.Neuroprotective diet (in development) — Gene's forthcoming review paper proposing a diet combining the best of MIND, DASH, and Mediterranean patterns.Studies:Multi-domain Alzheimer's Prevention Trial — Observational study where Gene's nutritional risk index predicted cognitive decline/enhancement.Framingham cohort study — Used by a Dutch research group to validate the same three biomarkers, finding a 4–5x dementia risk increase with suboptimal levels.Oregon Brain Aging Study — Gene's ~15–20-year-old study of exceptionally healthy elderly "superagers" showing optimal (not just non-deficient) nutrient thresholds matter.Omega-3 RCT (APOE4) — Gene's 3-year placebo-controlled trial showing omega-3s especially benefit APOE4 carriers' neuronal integrity.